MAPT and Cognitive impairment: The precise mechanisms of cognitive impairment in PD still remain unknown, but it was widely acknowledged that the combination of pathological protein accumulations (alpha synuclein, tau, and amyloid beta) and neurotransmitter changes plays an important role in cognitive involvement (Weil et al., 2018).